Predicting Biological Activity of 2,4,6-trisubstituted 1,3,5-triazines Using Random Forest

  • Ahmed H. Abu El-Atta
  • M. I. Moussa
  • Aboul Ella Hassanien
Conference paper
Part of the Advances in Intelligent Systems and Computing book series (AISC, volume 303)


This paper presents an approach to predict the activity of analogues of 2,4,6-trisubstituted 1,3,5-triazines as cannabinoid receptor (CB2) agonists using random forest technique. We compute twenty molecular descriptors for a data set of 58 analogues for the component, and depending on values of these descriptors we train random forest to find a relation between biological activity and molecular structure of analogues. The results obtained by random forest were compared with the decision tree and support vector machine classifiers and the random forest has 100% overall predicting accuracy and for decision tree and support vector machine were 93% and 67% respectively.


QSAR model CB2 agonists Decision tree Random forest and Molecular descriptors 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Yrj, S., Kalliokoski, T., Laitinen, T., Poso, A., Parkkari, T., Nevalainen, T.: Discovery of novel cannabinoid receptor ligands by a virtual screening approach: Further development of 2,4,6-trisubstituted 1,3,5-triazines as CB2 agonists. Eur. J. Pharm. Sci. 48(1-2), 9–20 (2013)CrossRefGoogle Scholar
  2. 2.
    Gutman, I., Rusci, B., Trinajsti, N., Wilcox, C.F.: Graph theory and molecular orbitals. XII. Acyclic polyenes. J. Chem. Phys. 62, 3399–3405 (1975)CrossRefGoogle Scholar
  3. 3.
    Kier, L.B., Hall, L.H.: Molecular Connectivity in Structure-Activity Analysis. RSP-Wiley, Chetster (1986)Google Scholar
  4. 4.
    Sharma, V., Goswami, R., Madan, A.K.: Eccentric connectivity index: A novel highly discriminating topological descriptor for structure-property and structure-activity studies. J. Chem. Inf. Comput. Sci. 37, 273–282 (1997)CrossRefGoogle Scholar
  5. 5.
    Gupta, S., Singh, M., Madan, A.K.: Superpendentic index: A novel topological descriptor for predicting biological activity. J. Chem. Inf. Comput. Sci. 39, 272–277 (1999)CrossRefGoogle Scholar
  6. 6.
    Wiener, H.: Correlation of heat of isomerization and difference in heat of vaporization of isomers among paraffin hydrocarbons. J. Am. Chem. Soc. 69, 17–20 (1947)CrossRefGoogle Scholar
  7. 7.
    Todeschini, R., Consonni, V.: Molecular Descriptors for Chemoinformatics, vol. 1, pp. 1–955. Wiley VCH, Weinheim (2009)Google Scholar
  8. 8.
    Dutt, R., Madan, A.K.: Predicting biological activity: Computational approach using novel distance based molecular descriptors. Computers in Biology and Medicine 42, 1026–1041 (2012)CrossRefGoogle Scholar
  9. 9.
    Tetko, I.V., Gasteiger, J., Todeschini, R., Mauri, A., Livingstone, D., Ertl, P., Palyulin, V.A., Radchenko, E.V., Zefirov, N.S., Makarenko, A.S., Tanchuk, V.Y., Prokopenko, V.V.: Virtual computational chemistry laboratory-design and description. J. Comput.-Aided Mol. Des. 19, 453–463 (2005)CrossRefGoogle Scholar
  10. 10.
    Cios, K., Pedrycz, W., Swiniarski, R., Kurgan, L.: Data Mining: A Knowledge Discovery Approach. Springer (2007)Google Scholar
  11. 11.
    Svetnik, V., Liaw, A., Tong, C., Culberson, J.C., Sheridan, R.P., Feuston, B.P.: Random forest: a classification and regression tool for compound classification and QSAR modeling. J. Chem. Inf. Comput. Sci. 43, 1947–1958 (2003)CrossRefGoogle Scholar
  12. 12.
    Breiman, L.: Random Forests. Machine Learning 45(1), 5–32 (2001)CrossRefzbMATHGoogle Scholar
  13. 13.
    Zhang, Q.-U., Aires-de-Sousa, J.: Random Forest Prediction of Mutagenicity from Empirical Physicochemical Descriptors. J. Chem. Inf. Mod. 47, 1–8 (2007)CrossRefGoogle Scholar
  14. 14.
    Prasad, A.M., Iverson, L.R., Liaw, A.: Newer Classification and Regression Tree Techniques: Bagging and Random Forests for Ecological Prediction. Ecosystems 9, 181–199 (2006)CrossRefGoogle Scholar
  15. 15.
    Guha, R., Jurs, P.C.: Development of Linear, Ensemble, and Nonlinear Models for the Prediction and Interpretation of the Biological Activity of a Set of PDGFR Inhibitors. J. Chem. Inf. Comp. Sci. 44, 2179–2189 (2004)CrossRefGoogle Scholar
  16. 16.
    Han, L., Wang, Y., Bryant, S.H.: Developing and validating predictive decision tree models from mining chemical structural fingerprints and high through- output data in PubChem. BMC Bioinformat. 9, 401 (2008)CrossRefGoogle Scholar
  17. 17.
    Lamanna, C., Bellini, M., Padova, A., Westerberg, G., Maccari, L.: Straightforward recursive partitioning model for discarding insoluble compounds in the drug discovery process. J. Med. Chem. 51, 2891–2897 (2008)CrossRefGoogle Scholar
  18. 18.
    Matthews, B.W.: Comparison of the predicted and observed secondary structure of T4 phage Lysozyme. Biochim. Biophys. Acta 405, 442–451 (1975)CrossRefGoogle Scholar
  19. 19.
    Goyal, R.K., Dureja, H., Singh, G., Madan, A.K.: Models for Antitubercular Activity of 5’-O-[(N-Acyl)sulfamoyl]adenosines. Scientia Pharmaceutica 78, 791–820 (2010)CrossRefGoogle Scholar
  20. 20.
    Das, K.C., Gutman, I.: Some properties of the second Zagreb index. Match. Commun. Math. Comput. Chem. 52, 103–112 (2004)zbMATHMathSciNetGoogle Scholar
  21. 21.
    Todeschini, R., Gramatica, P.: New 3D molecular descriptors: the WHIM theory and QSAR applications. Perspect. Drug Discov. Des. 2, 355–380 (1998)CrossRefGoogle Scholar
  22. 22.
    K. S, D.-W. M, and P. N.: Trends in drug development time and price. Abstracts of Academy Health Meetings 22, 36–76 (2005)Google Scholar
  23. 23.
    Lewis, R.A.: A general method for exploiting QSAR models in lead optimization. J. Med. Chem. 48, 1638–1648 (2005)CrossRefGoogle Scholar
  24. 24.
    Turner, J.V., Maddalena, D.J., Cutler, D.J.: Pharmacokinetic parameter prediction from drug structure using artificial neural networks. Int. J. Pharm. 270, 209–219 (2004)CrossRefGoogle Scholar
  25. 25.
    Matsuda, L.A., Lolait, S.J., Brownstein, M.J., Young, A.C., Bonner, T.I.: Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561–564 (1990)CrossRefGoogle Scholar
  26. 26.
    Munro, S., Thomas, K.L., Abu-Shaar, M.: Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 61–65 (2003)CrossRefGoogle Scholar
  27. 27.
    Pacher, P., Batkai, S., Kunos, G.: The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol. Rev. 58, 389–462 (2006)CrossRefGoogle Scholar
  28. 28.
    Basavarajappa, B.S.: Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity. Curr. Neuropharmacol. 5, 81–97 (2007)CrossRefGoogle Scholar
  29. 29.
    Yates, M.L., Barker, E.L.: Inactivation and biotransformation of the endogenous cannabinoids anandamide and 2-arachidonoylglycerol. Mol. Pharmacol. 76, 11–17 (2009)CrossRefGoogle Scholar
  30. 30.
    Di Marzo, V.: Targeting the endocannabinoid system: to enhance or reduce. Nat. Rev. Drug. Discov. 7, 438–455 (2008)CrossRefGoogle Scholar
  31. 31.
    Pacher, P., Mechoulam, R.: Is lipid signaling through cannabinoid 2 receptors part of a protective system. Prog. Lipid Res. 50, 193–211 (2011)CrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2014

Authors and Affiliations

  • Ahmed H. Abu El-Atta
    • 1
    • 2
  • M. I. Moussa
    • 2
  • Aboul Ella Hassanien
    • 1
    • 3
  1. 1.Scientific Research Group in Egypt (SRGE), egyptscience.netCairoEgypt
  2. 2.Faculty of Computers and InformationBenha UniversityBenhaEgypt
  3. 3.Faculty of Computers and InformationCairo UniversityCairoEgypt

Personalised recommendations